文献速递胃肠外科

机器人与腹腔镜胃癌根治术五年长期结局对比:大型单中心队列研究

Five-year long-term comparison of robotic and laparoscopic gastrectomy for gastric cancer: a large single-center cohort study.
PubMed 文献 · Surg Endosc · 2023-05-19

主要终点为5年无病生存(DFS)和总生存(OS)。两组5年DFS率分别为67.28%和70.41%,5年OS率分别为69.01%和69.58%,DFS(HR=1.08,95%CI 0.83-1.39,Log-rank P=0.557)与OS(HR=1.02,95%CI 0.78-1.34,Log-rank P=0.850)均无显著差异。亚组分析中除病理III期和病理N3期外,两组5年DFS和OS无显著差异(P>0.05)。结论认为早期胃癌患者两种入路长期生存相似,进展期胃癌机器人手术的长期生存结局仍需进一步研究。

要点

  • 匹配后机器人组与腹腔镜组5年DFS和OS均无显著差异。
  • 早期胃癌患者机器人手术与腹腔镜手术长期生存相似。
  • 病理III期和N3期亚组两组生存差异显著,需进一步研究。

核心结论

  • 对于早期胃癌,机器人与腹腔镜胃癌根治术的长期生存相似。
  • 对于进展期胃癌,机器人胃癌根治术的长期生存结局仍需进一步研究评估。

研究设计与样本

  • 采用倾向性评分匹配(PSM)匹配组间,主要终点为5年无病生存(DFS)和总生存(OS)。
  • 匹配后纳入机器人组283例、腹腔镜组701例进行分析。

主要发现

  • 5年累积DFS率机器人组为67.28%,腹腔镜组为70.41%。
  • 5年OS率机器人组为69.01%,腹腔镜组为69.58%。
  • DFS的Kaplan-Meier生存曲线无显著差异(HR=1.08,95%CI 0.83-1.39,Log-rank P=0.557)。
  • OS的Kaplan-Meier生存曲线无显著差异(HR=1.02,95%CI 0.78-1.34,Log-rank P=0.850)。
  • 亚组分析中,除病理III期和病理N3期患者外(P<0.05),两组5年DFS和5年OS无显著差异(P>0.05)。

临床怎么用

  • 对于早期胃癌,机器人胃癌根治术可作为与腹腔镜手术长期生存相当的选项。
  • 对于病理III期或N3期进展期胃癌,选择机器人手术时应充分告知长期生存证据尚不充分。

局限性

  • 本研究为单中心回顾性队列研究,结论的外推需谨慎。
  • 进展期胃癌机器人手术的长期生存结局仍需进一步研究评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robotic gastrectomy (RG) has been reported to be technically feasible and safe for patients with gastric cancer. However, 5-year long-term survival and recurrence outcomes for advanced gastric cancer have rarely been reported. This study aimed to compare the long-term oncologic outcomes between RG and laparoscopic gastrectomy (LG) for gastric cancer. METHODS: The general clinicopathological data of 1905 consecutive patients who underwent RG and LG were retrospectively collected at the Chinese People's Liberation Army General Hospital between November 2011 and October 2017. Propensity score matching (PSM) was used to match groups. The primary endpoints were 5-year disease-free survival (DFS) and overall survival (OS). RESULTS: After PSM, a well-balanced cohort of 283 patients in the RG group and 701 patients in the LG group were included in the analysis. The 5-year cumulative DFS rates were 67.28% in the robotic group and 70.41% in the laparoscopic group. The 5-year OS rate was 69.01% in the robotic group and 69.58% in the laparoscopic group. No significant differences in Kaplan-Meier survival curves for DFS (HR = 1.08, 95% CI 0.83-1.39, Log-rank P = 0.557) and OS (HR = 1.02, 95% CI 0.78-1.34, Log-rank P = 0.850) were observed between the 2 groups. In the subgroup analyses for potential confounding variables, there were no significant differences in 5-year DFS and 5-year OS survival between the 2 groups (P > 0.05), except for patients with pathological stage III and pathological stage N3 (P < 0.05). CONCLUSION: For patients with early gastric cancer, robotic and laparoscopic approaches have similar long-term survival. For patients with advanced gastric cancer, further studies need to be conducted to assess the long-term survival outcomes of RG.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Liang W, Huang J, Song L, et al. Five-year long-term comparison of robotic and laparoscopic gastrectomy for gastric cancer: a large single-center cohort study. Surg Endosc. 2023. PMID: 37208483. doi:10.1007/s00464-023-10125-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。